Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD

CRIC Study Investigators

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Abstract

Rationale & Objective: A large residual risk for atherosclerotic cardiovascular disease (ASCVD) remains in the setting of chronic kidney disease (CKD) despite treatment with statins. We sought to evaluate the associations of lipid and apolipoprotein levels with risk for ASCVD in individuals with CKD. Study Design: Prospective cohort study. Settings & Participants: Adults aged 21 to 74 years with non–dialysis-dependent CKD at baseline enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study in 7 clinical study centers in the United States. Predictor: Baseline total cholesterol, non–high-density lipoprotein cholesterol (non–HDL-C), very low-density lipoprotein cholesterol (VLDL-C), triglycerides, low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo-B), HDL-C, and apolipoprotein AI (Apo-AI) values stratified into tertiles. Outcome: A composite ASCVD event of myocardial infarction or ischemic stroke. Analytic Approach: Multivariable Cox proportional hazards regression to estimate the risk for ASCVD for each tertile of lipoprotein predictor. Results: Among 3,811 CRIC participants (mean age, 57.7 years; 41.8% white), there were 451 ASCVD events during a median follow-up of 7.9 years. There was increased ASCVD risk among participants with VLDL-C levels in the highest tertile (HR, 1.28; 95% CI, 1.01-1.64), Apo-B levels in the middle tertile (HR, 1.30; 95% CI, 1.03-1.64), HDL-C levels in the middle and lowest tertiles (HRs of 1.40 [95% CI, 1.08-1.83] and 1.77 [95% CI, 1.35-2.33], respectively), and Apo-AI levels in the middle and lowest tertiles (HRs of 1.77 [95% CI, 1.02-1.74] and 1.77 [95% CI, 1.36-2.32], respectively). LDL-C level was not significantly associated with the ASCVD outcome in this population (HR, 1.00 [95% CI, 0.77-1.30] for the highest tertile). Limitations: Associations based on observational data do not permit inferences about causal associations. Conclusions: Higher VLDL-C and Apo-B levels, as well as lower HDL-C and Apo-AI levels, are associated with increased risk for ASCVD. These findings support future investigations into pharmacologic targeting of lipoproteins beyond LDL-C, such as triglyceride-rich lipoproteins, to reduce residual risk for ASCVD among individuals with CKD.

Original languageEnglish (US)
Pages (from-to)827-836
Number of pages10
JournalAmerican Journal of Kidney Diseases
Volume73
Issue number6
DOIs
StatePublished - Jun 2019

Keywords

  • Lipids
  • apolipoprotein
  • atherosclerotic cardiovascular disease (ASCVD)
  • chronic kidney disease (CKD)
  • high-density lipoprotein cholesterol (HDL-C)
  • ischemic stroke
  • myocardial infarction (MI)
  • triglyceride
  • very low-density lipoprotein cholesterol (VLDL-C)

ASJC Scopus subject areas

  • Nephrology

Fingerprint

Dive into the research topics of 'Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD'. Together they form a unique fingerprint.

Cite this